Spectrum Pharmaceuticals (NASDAQ:SPPI) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 25 percent increase over losses of $(0.16) per share from the same period last year.
Fortress Biotech Announces 1-For-15 Reverse Stock Split
Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress" or the "Company"), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products
